Name

Bovogen Biologicals

Legal name

Bovogen Biologicals Pty Ltd

Website

https://bovogen.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Animal Serum and Protein Manufacturing

NAICS

Rendering and Meat Byproduct Processing (311613)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Veterinary Vaccine & Biologics Distributors (HLAMAIAC)

akta.pro secondary industries

Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO) (HLAMAKAI), Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM)

Keywords

• Animal serum products
• Bovine serum albumin
• Cell culture media
• Biopharmaceutical manufacturing
• Specialty protein products

Headquarters

HQ city

Keilor

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Animal Serum Products: Manufacturing and supply of specialty serums including Foetal Bovine Serum, Newborn Calf Serum, and Adult Bovine Serum sourced from Australia, New Zealand, and France. Products are sold directly to pharmaceutical, biotech, diagnostics, and research customers globally.
2. Purified Protein Products: Manufacturing and supply of purified animal proteins including Bovine Serum Albumin (Bovostar brand) and Bovine Immunoglobulin for life science applications in cell culture, diagnostics, pharmaceuticals, and research.
3. Contract Manufacturing Services: Provides contract sterile filtration, bioprocess manufacturing, and lyophilisation services to the life sciences sector. Services include procurement of raw materials, sterile filtration, labelling, packaging, warehousing, and quality control/assurance.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels3 records

Core offering

Bovogen Biologicals manufactures and supplies specialty animal serums (Foetal Bovine Serum, Newborn Calf Serum, Adult Bovine Serum) and purified animal proteins (Bovine Serum Albumin, Bovine Immunoglobulin) under GMP-aligned processes for pharmaceutical, biotechnology, diagnostics, vaccine, and life science research customers worldwide. The company also provides contract bioprocessing services including sterile filtration, lyophilisation, and biomanufacturing from its Melbourne facility.

Product overview

Bovogen Biologicals is an Australian biotech company manufacturing and supplying animal serums, highly purified animal proteins, enzymes, and specialty products for the pharmaceutical, diagnostics, veterinary, vaccine, biotechnology, research, and nutritional industries globally. The product portfolio centers on specialty serums (Foetal Bovine Serum in multiple origins including NZ, Australia, France; Newborn Calf Serum; Adult Bovine Serum; Foetal Bovine Serum Ultra Low IgG) and purified proteins (Bovine Serum Albumin under the Bovostar brand including standard and lipid fortified BovoLep variants; Bovine Immunoglobulin). The company offers contract manufacturing services including sterile filtration, bioprocess manufacturing, and lyophilisation (freeze drying). All products are manufactured in Melbourne, Australia under strict GMP conditions with full traceability from Australian and New Zealand origin raw materials.

Differentiator

Problem solved

Functional benefit

Brands

• Bovostar: Premium grade Bovine Serum Albumin (BSA) brand offering ultra high purity, low endotoxin, and consistent batch-to-batch properties.
• BovoLep

Products and services

• Foetal Bovine Serum (Australian origin) Sterile Foetal Bovine Serum sourced from Australia, manufactured in a fully validated sterile filtration facility with a closed loop filtration train and triple 0.1µm filtration process. Used as a growth media additive for tissue and cell culture and vaccine development by pharmaceutical and biotech customers.
• Foetal Bovine Serum (New Zealand origin) Sterile Foetal Bovine Serum sourced from New Zealand, manufactured under strict GMP conditions with triple 0.1µm sterile filtration. Features fully traceable origin from registered export abattoirs under Government Veterinary supervision.
• Foetal Bovine Serum (French origin) Sterile Foetal Bovine Serum of French origin, manufactured with triple 0.1µm sterile filtration process under GMP conditions. Complies with FDA regulations 21 CFR 211.72.
• Foetal Bovine Serum (Other origins) Foetal Bovine Serum available from origins other than Australia, New Zealand, or France upon request.
• Newborn Calf Serum Sterile Newborn Calf Serum sourced from New Zealand animals less than 10 days of age. Manufactured in a closed loop system with single 0.1µm sterile filtration, providing low endotoxin and haemoglobin levels for life science and cell culture use.
• Adult Bovine Serum Sterile Adult Bovine Serum collected to minimize haemoglobin and endotoxin levels, processed in a validated sterile filtration facility. Available in Australian and New Zealand origins for cell culture and research applications.
• Foetal Bovine Serum Ultra Low IgG Foetal Bovine Serum with IgG removed using a proprietary chromatographic process, retaining cellular viability and biological growth promoting activity. Total IgG specification <0.5 ug/ml (ELISA). Used in cell culture and protein purification applications where reduced IgG is required.
• Bovine Serum Albumin (Bovostar) Premium grade Bovine Serum Albumin (BSA) Fraction V manufactured using a proprietary two-step purification/heat shock process. Features ultra high purity, low immunoglobulin, low endotoxin, low fatty acid content, and bovine virus free status. Applications include cell culture media additive, protein standard, vaccine production, and blocking agent in immunoassays.
• Bovine Serum Albumin Lipid Fortified (BovoLep) Highly purified BSA fortified with non-animal synthetic lipids for enhanced growth of fastidious organisms such as Leptospira. Used for mammalian cell culture applications where essential lipid nutrients are absent in standard purified BSA fractions.
• Bovine Immunoglobulin Purified bovine immunoglobulin from plasma or serum using salt precipitation and centrifugation at low temperature. Final lyophilised product is a crystalline powder. Applications include cell culture, in-vitro diagnostics, pharmaceuticals, molecular biology, serology, and immune supplements for neonatal animals.
• Contract Sterile Filtration Services Contract sterile filtration and manufacturing services for animal sera, general and industrial reagents and related products. Utilizes fully disposable/closed loop systems with a state-of-the-art validated sterile filtration facility consisting of numerous processing rooms serviced by HEPA filtered air.
• Contract Bioprocess Manufacturing Services Bioprocessing services utilizing Bovogen's technical expertise and experience with a diversity of highly specialized manufacturing equipment serving a wide industry sector.
• Contract Lyophilisation (Freeze Drying) Services Bulk product lyophilisation services with one of the largest capacity lyophilisers used for bioprocessing in Australia. Features a fully validated 1000 litre ice capacity lyophiliser PLC controlled for optimal drying and consistency between batch cycles.

Quantifiable outcome

• Products exported to 45+ countries across five continents
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and major.

• ANZCO FoodscoreStrategic or Co-development PartnerParent company acquisition in late 2016. ANZCO Foods, a vertically integrated beef/lamb marketing company established in Japan in 1984 and 100% owned by Itoham Foods (Mitsubishi Corporation as major shareholder), acquired Bovogen Biologicals. ANZCO provides consistent supply of high-quality controlled raw materials (serum and plasma) with long-term supply guarantee and real-time fully traceable material lines.
• Scientifix Pty LtdcoreChannel Partner/ Reseller/ DistributorExclusive distributor of Bovogen products in Australia. Contact: 1800 007 900, [email protected]
• Nova Biologics InccoreChannel Partner/ Reseller/ DistributorDistributor of Bovogen Biologicals Sterile Foetal Bovine Serum, Bovine Serum Albumin and Specialty Nutraceutical Ingredients in California, USA. Contact: 760 630 5700, [email protected]
• Catus Biotech GmbHcoreChannel Partner/ Reseller/ DistributorAgent of Bovogen Biologicals Sterile Foetal Bovine Serum and Bovine Serum Albumin in Germany. Contact: +49 8158 7406, [email protected]
• Jain Biologicals Pvt LtdcoreChannel Partner/ Reseller/ DistributorDistributor of Bovogen Biologicals Sterile Foetal Bovine Serum in Chandigarh, India. Contact: 172 261 4132
• Moregate BiotechmajorStrategic or Co-development PartnerANZCO Foods (parent company) acquired Moregate Biotech in 2022, a globally recognized biotechnology business manufacturing Australian- and New Zealand-sourced animal sera, animal proteins, enzymes, and specialty products. Moregate Biotech operates facilities in Brisbane, Australia and Hamilton, New Zealand, exporting to Europe, India, Asia, and the United States. The acquisition complements ANZCO's existing Bovogen business.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Cytiva (HyClone): Global leader in cell culture media and animal serum products (HyClone FBS) for biopharmaceutical manufacturing. Directly comparable to Bovogen's FBS and specialty serum portfolio but with much broader portfolio scale and entrenched relationships with major vaccine manufacturers.
• Thermo Fisher Scientific (Life Sciences): Operates one of the world's largest FBS and specialty serum product lines through its Life Sciences segment. Competes directly with Bovogen in serving biopharma, vaccine, and diagnostic customers with broader geographic footprint and integrated bioprocessing offerings.
• Merck (Sigma-Aldrich) Bioprocessing: Markets FBS, BSA, and cell culture supplements under the Sigma-Aldrich brand. Directly comparable product portfolio to Bovogen with broader catalog reach and stronger presence in academic research channels globally.

Direct peers

• Moregate Biotech: Australian and New Zealand-based manufacturer of animal sera, proteins, enzymes, and specialty biotech products. Now sister company under ANZCO Foods (parent of Bovogen) following 2022 acquisition; the closest direct comparable in origin geography, product mix, and customer base.
• Gemini Bio: US-based manufacturer of FBS, newborn calf serum, and other animal-derived cell culture products. Direct competitor serving similar biopharma and research customer base, with comparable specialization in USDA-approved origin serum products.
• Atlanta Biologicals (R&D Systems / Bio-Techne): Supplier of FBS, serum alternatives, and cell culture reagents to research and diagnostic customers. Direct peer in the specialty animal serum category with overlapping customer segments in life science research and diagnostics manufacturing.
• Valley Biomedical: Specialty processor of human and animal serum products, including FBS and bovine serum derivatives for diagnostic and research applications. Comparable B2B biologics manufacturer with custom processing capabilities similar to Bovogen's contract services.
• Capricorn Scientific: German-based manufacturer of FBS, bovine serum products, and cell culture media for biopharma and diagnostic applications. Comparable specialty serum producer serving European customers with similar GMP-grade positioning to Bovogen's certified products.
• Rocky Mountain Biologicals: US-based specialty manufacturer of FBS, animal serums, and cell culture media for research and diagnostic customers. Direct comparable in specialty serum manufacturing with similar focus on documented origin and quality certifications.

Emerging players

• Seroxra (Animal Serum Specialist): Specialty animal serum supplier focusing on cell culture applications for biotech customers. Smaller-scale competitor with overlapping product portfolio to Bovogen, particularly in research-grade FBS and specialty serum variants.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bovogen-biologicals-pty-ltd-

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bovogen Biologicals